Atossa Therapeutics, Inc.
ATOS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001488039
No open-market purchases or sales by Atossa Therapeutics, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $2.60M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Atossa Therapeutics, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 83 | 2 | 73 | −8 |
| Shares | 35.8M | 126.4K | 23.3M | −12.4M (−34.8%) |
| Value | $45.4M | $158.0K | $25.4M | −$19.9M (−43.9%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Atossa Therapeutics, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 2,225,800 | $2.43M | 0.10% |
| Millennium Management LLC | 1,534,502 | $1.67M | 0.00% |
| Ergoteles LLC | 514,600 | $561.0K | 0.02% |
| Bank of Montreal | 309,600 | $365.0K | 0.00% |
| Qube Research & Technologies Ltd | 105,671 | $115.0K | 0.00% |
| LMR Partners LLP | 41,730 | $45.0K | 0.00% |
| Alpine Global Management, LLC | 37,089 | $40.0K | 0.01% |
| HRT Financial LP | 29,904 | $32.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 20,201 | $22.0K | 0.00% |
| Pinz Capital Management, LP | 17,900 | $20.0K | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 16,912 | $18.0K | 0.00% |
| Two Sigma Securities, LLC | 12,755 | $14.0K | 0.00% |
| Game Plan Financial Advisors, LLC | 10,000 | $11.0K | 0.01% |
| Harbour Investments, Inc. | 1,711 | $2.00K | 0.00% |
| Federated Hermes, Inc. | 668 | $1.00K | 0.00% |
| Cutler Group LP | 1,800 | $1.00K | 0.00% |
Sold out (24)
Institutions that held Atossa Therapeutics, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Atossa Therapeutics, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 111,898 | $140.0K |
| Amalgamated Financial Corp. | 14,526 | $18.0K |